Dept. of Medical Sciences, Università degli Studi, Milan, Italy.
Mol Cell Endocrinol. 2012 Apr 4;351(2):342-50. doi: 10.1016/j.mce.2012.01.013. Epub 2012 Jan 25.
Patients with PS or non-syndromic deafness were submitted to genetic/functional analyzes of SLC26A4, of its binding domain for FOXI1 (FOXI1-DBD), of the transcription activator FOXI1, and of the potassium channel KCNJ10. SLC26A4 was the most frequently mutated gene. An altered intracellular localization with immunocytochemistry, and a hampered maturation process were demonstrated for two novel SLC26A4 variants. Biochemical and immunocytochemical analyzes led to the development of a more sensitive fluorometric functional assay able to reveal the partial loss-of-function of SLC26A4 mutations. A novel missense variant was found in FOXI1 gene, though functional analysis showed no significant impairment in the transcriptional activation of SLC26A4. Finally, 3 patients were found to harbor a variant in KCNJ10, which was classified as polymorphism. The novelty of the study resides in the analysis of all the 4 candidate genetic loci linked to PS/non-syndromic deafness, and in the precise definition of the thyroid phenotype. PS was invariably associated with biallelic mutations of SLC26A4, whereas the genetic origin of non-syndromic deafness remained largely undetermined, since monoallelic SLC26A4 variants accounted for one fourth of the cases and FOXI1 and KCNJ10 were not involved in this series.
患者 PS 或非综合征性耳聋进行 SLC26A4、其与 FOXI1 结合域(FOXI1-DBD)、转录激活因子 FOXI1 和钾通道 KCNJ10 的遗传/功能分析。SLC26A4 是最常突变的基因。通过免疫细胞化学显示两种新型 SLC26A4 变体的细胞内定位改变和成熟过程受阻。生化和免疫细胞化学分析导致开发出一种更敏感的荧光功能测定法,能够揭示 SLC26A4 突变的部分功能丧失。在 FOXI1 基因中发现了一种新的错义变体,但功能分析显示其对 SLC26A4 的转录激活没有明显的损害。最后,发现 3 名患者携带 KCNJ10 中的变体,该变体被归类为多态性。研究的新颖之处在于分析与 PS/非综合征性耳聋相关的所有 4 个候选遗传基因座,并精确定义甲状腺表型。PS 始终与 SLC26A4 的双等位基因突变相关,而非综合征性耳聋的遗传起源在很大程度上仍未确定,因为单等位基因 SLC26A4 变体占病例的四分之一,而 FOXI1 和 KCNJ10 未参与本系列研究。